Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Proposed health claims by Weider not based on "authoritative statements" -- FDA.

This article was originally published in The Tan Sheet

Executive Summary

ANTIOXIDANT/SUPPLEMENT HEALTH CLAIMS BASED ON USDA, NIH, CDC STATEMENTS BARRED because the statements are not "authoritative" as defined by the FDA Modernization Act, FDA says in nine interim final rules published in the June 22 Federal Register. The rules respond to notifications by Weider Nutrition International that it planned to use health claims for several vitamin and supplement products under the recently enacted FDAMA procedures providing for use of health claims without FDA preclearance if they are based on "authoritative statements" by government scientific bodies.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS088596

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel